KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Invested Capital (2016 - 2025)

Historic Invested Capital for Moderna (MRNA) over the last 10 years, with Q3 2025 value amounting to $9.4 billion.

  • Moderna's Invested Capital fell 2539.34% to $9.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 billion, marking a year-over-year decrease of 2539.34%. This contributed to the annual value of $11.0 billion for FY2024, which is 2402.11% down from last year.
  • Per Moderna's latest filing, its Invested Capital stood at $9.4 billion for Q3 2025, which was down 2539.34% from $9.5 billion recorded in Q2 2025.
  • In the past 5 years, Moderna's Invested Capital ranged from a high of $20.2 billion in Q4 2022 and a low of $4.0 billion during Q1 2021
  • Moreover, its 5-year median value for Invested Capital was $13.4 billion (2024), whereas its average is $13.5 billion.
  • In the last 5 years, Moderna's Invested Capital soared by 45316.82% in 2021 and then plummeted by 3252.38% in 2024.
  • Quarter analysis of 5 years shows Moderna's Invested Capital stood at $14.9 billion in 2021, then skyrocketed by 35.46% to $20.2 billion in 2022, then decreased by 28.56% to $14.4 billion in 2023, then decreased by 24.02% to $11.0 billion in 2024, then decreased by 14.38% to $9.4 billion in 2025.
  • Its last three reported values are $9.4 billion in Q3 2025, $9.5 billion for Q2 2025, and $10.1 billion during Q1 2025.